Cargando…

Low-Dose Dose–Response for In Vitro Nrf2-ARE Activation in Human HepG2 Cells

Kelch-like ECH-associated protein 1 (Keap1), nuclear factor erythroid 2-like factor 2-related factor 2 (Nrf2), and the antioxidant response element (ARE) are interacting components of a master regulatory signaling pathway that coordinates redox homeostasis, cytoprotective responses, and shifts in st...

Descripción completa

Detalles Bibliográficos
Autor principal: Bogen, Kenneth T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418914/
https://www.ncbi.nlm.nih.gov/pubmed/28515676
http://dx.doi.org/10.1177/1559325817699696
_version_ 1783234141869834240
author Bogen, Kenneth T.
author_facet Bogen, Kenneth T.
author_sort Bogen, Kenneth T.
collection PubMed
description Kelch-like ECH-associated protein 1 (Keap1), nuclear factor erythroid 2-like factor 2-related factor 2 (Nrf2), and the antioxidant response element (ARE) are interacting components of a master regulatory signaling pathway that coordinates redox homeostasis, cytoprotective responses, and shifts in stem cell state. This study reexamined detailed dose–response (DR) data reported for in vitro Nrf2-ARE activation in human hepatoblastoma HepG2 cell lines containing either a ARE-bla or ARE-luc reporter at 12 different concentrations of each of 15 chemicals. The normalized study data were combined among chemicals exhibiting a positive response, yielding n = 531 (179) DR data for 9 (7) chemicals using the ARE-bla (ARE-luc) assay. Three-parameter linear/kth-power regression fits obtained to each combined set of ARE-bla- or ARE-luc-assay response data provided good fits (R (2) = .99 or .91, respectively, P (fit) > .99) that each incorporate a highly significant negative initial linear slope (P = 4 × 10(−5) or .00025) and an overall J-shaped DR pattern. Results from this reanalysis of high-resolution ARE response data support the hypothesis that nonlinear ARE-mediated adaptive cellular responses to oxidative stress are governed by an ultrasensitive molecular switch.
format Online
Article
Text
id pubmed-5418914
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-54189142017-05-17 Low-Dose Dose–Response for In Vitro Nrf2-ARE Activation in Human HepG2 Cells Bogen, Kenneth T. Dose Response Original Article Kelch-like ECH-associated protein 1 (Keap1), nuclear factor erythroid 2-like factor 2-related factor 2 (Nrf2), and the antioxidant response element (ARE) are interacting components of a master regulatory signaling pathway that coordinates redox homeostasis, cytoprotective responses, and shifts in stem cell state. This study reexamined detailed dose–response (DR) data reported for in vitro Nrf2-ARE activation in human hepatoblastoma HepG2 cell lines containing either a ARE-bla or ARE-luc reporter at 12 different concentrations of each of 15 chemicals. The normalized study data were combined among chemicals exhibiting a positive response, yielding n = 531 (179) DR data for 9 (7) chemicals using the ARE-bla (ARE-luc) assay. Three-parameter linear/kth-power regression fits obtained to each combined set of ARE-bla- or ARE-luc-assay response data provided good fits (R (2) = .99 or .91, respectively, P (fit) > .99) that each incorporate a highly significant negative initial linear slope (P = 4 × 10(−5) or .00025) and an overall J-shaped DR pattern. Results from this reanalysis of high-resolution ARE response data support the hypothesis that nonlinear ARE-mediated adaptive cellular responses to oxidative stress are governed by an ultrasensitive molecular switch. SAGE Publications 2017-05-03 /pmc/articles/PMC5418914/ /pubmed/28515676 http://dx.doi.org/10.1177/1559325817699696 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Bogen, Kenneth T.
Low-Dose Dose–Response for In Vitro Nrf2-ARE Activation in Human HepG2 Cells
title Low-Dose Dose–Response for In Vitro Nrf2-ARE Activation in Human HepG2 Cells
title_full Low-Dose Dose–Response for In Vitro Nrf2-ARE Activation in Human HepG2 Cells
title_fullStr Low-Dose Dose–Response for In Vitro Nrf2-ARE Activation in Human HepG2 Cells
title_full_unstemmed Low-Dose Dose–Response for In Vitro Nrf2-ARE Activation in Human HepG2 Cells
title_short Low-Dose Dose–Response for In Vitro Nrf2-ARE Activation in Human HepG2 Cells
title_sort low-dose dose–response for in vitro nrf2-are activation in human hepg2 cells
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418914/
https://www.ncbi.nlm.nih.gov/pubmed/28515676
http://dx.doi.org/10.1177/1559325817699696
work_keys_str_mv AT bogenkennetht lowdosedoseresponseforinvitronrf2areactivationinhumanhepg2cells